217 related articles for article (PubMed ID: 29360641)
1. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
[TBL] [Abstract][Full Text] [Related]
2. The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma.
Keld R; Guo B; Downey P; Gulmann C; Ang YS; Sharrocks AD
Mol Cancer; 2010 Dec; 9():313. PubMed ID: 21143918
[TBL] [Abstract][Full Text] [Related]
3. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
Oh S; Shin S; Janknecht R
Biochim Biophys Acta; 2012 Aug; 1826(1):1-12. PubMed ID: 22425584
[TBL] [Abstract][Full Text] [Related]
4. COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
Vitari AC; Leong KG; Newton K; Yee C; O'Rourke K; Liu J; Phu L; Vij R; Ferrando R; Couto SS; Mohan S; Pandita A; Hongo JA; Arnott D; Wertz IE; Gao WQ; French DM; Dixit VM
Nature; 2011 May; 474(7351):403-6. PubMed ID: 21572435
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.
Carrero ZI; Kollareddy M; Chauhan KM; Ramakrishnan G; Martinez LA
Oncotarget; 2016 Mar; 7(11):12554-67. PubMed ID: 26871468
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity.
Baert JL; Monte D; Verreman K; Degerny C; Coutte L; de Launoit Y
Oncogene; 2010 Mar; 29(12):1810-20. PubMed ID: 20062082
[TBL] [Abstract][Full Text] [Related]
7. Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanoma.
Pedini F; De Luca G; Felicetti F; Puglisi R; Boe A; Arasi MB; Fratini F; Mattia G; Spada M; Caporali S; Biffoni M; Giuliani A; Carè A; Felli N
Mol Oncol; 2019 Sep; 13(9):1836-1854. PubMed ID: 31115969
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of ETV4 at Ser73 by ERK kinase could block ETV4 ubiquitination degradation in colorectal cancer.
Xiao J; Yang S; Shen P; Wang Y; Sun H; Ji F; Zhou D
Biochem Biophys Res Commun; 2017 May; 486(4):1062-1068. PubMed ID: 28373072
[TBL] [Abstract][Full Text] [Related]
9. ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa.
Dissanayake K; Toth R; Blakey J; Olsson O; Campbell DG; Prescott AR; MacKintosh C
Biochem J; 2011 Feb; 433(3):515-25. PubMed ID: 21087211
[TBL] [Abstract][Full Text] [Related]
10. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
O'Hagan RC; Hassell JA
Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin ligase COP1 coordinates transcriptional programs that control cell type specification in the developing mouse brain.
Newton K; Dugger DL; Sengupta-Ghosh A; Ferrando RE; Chu F; Tao J; Lam W; Haller S; Chan S; Sa S; Dunlap D; Eastham-Anderson J; Ngu H; Hung J; French DM; Webster JD; Bolon B; Liu J; Reja R; Kummerfeld S; Chen YJ; Modrusan Z; Lewcock JW; Dixit VM
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11244-11249. PubMed ID: 30322923
[TBL] [Abstract][Full Text] [Related]
12. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
Liu CY; Yu T; Huang Y; Cui L; Hong W
J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
[TBL] [Abstract][Full Text] [Related]
13. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
[TBL] [Abstract][Full Text] [Related]
14. Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespib.
Acquaviva J; Smith DL; Jimenez JP; Zhang C; Sequeira M; He S; Sang J; Bates RC; Proia DA
Mol Cancer Ther; 2014 Feb; 13(2):353-63. PubMed ID: 24398428
[TBL] [Abstract][Full Text] [Related]
15. Overlapping functions of Pea3 ETS transcription factors in FGF signaling during zebrafish development.
Znosko WA; Yu S; Thomas K; Molina GA; Li C; Tsang W; Dawid IB; Moon AM; Tsang M
Dev Biol; 2010 Jun; 342(1):11-25. PubMed ID: 20346941
[TBL] [Abstract][Full Text] [Related]
16. E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis.
Montagnani V; Maresca L; Apollo A; Pepe S; Carr RM; Fernandez-Zapico ME; Stecca B
J Biol Chem; 2020 Nov; 295(47):16058-16071. PubMed ID: 32938713
[TBL] [Abstract][Full Text] [Related]
17. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
[TBL] [Abstract][Full Text] [Related]
18. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
[TBL] [Abstract][Full Text] [Related]
19. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
